Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristi Baker

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|January 21, 2015
Regulation of immune responses by the neonatal fc receptor and its therapeutic implicationsTimo Rath, Kristi Baker, Michal Pyzik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosisInti Zlobec, Kristi Baker, Luigi M Terracciano, et al.
International Journal of Molecular Sciences|August 18, 2017
A Critical Review on the Effect of Docosahexaenoic Acid (DHA) on Cancer Cell Cycle ProgressionMarnie Newell, Kristi Baker, Lynne M Postovit, et al.
Histopathology|November 1, 2011
Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancersInti Zlobec, Parham Minoo, Luigi Terracciano, et al.
Frontiers in Immunology|June 12, 2023
Short chain fatty acids prime colorectal cancer cells to activate antitumor immunityCourtney Mowat, Jasmine Dhatt, Ilsa Bhatti, et al.
Frontiers in Immunology|October 3, 2025
Correction: Short chain fatty acids prime colorectal cancer cells to activate antitumor immunityCourtney Mowat, Jasmine Dhatt, Ilsa Bhatti, et al.
The Journal of Experimental Medicine|July 23, 2021
Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN-driven CCL5 and CXCL10Courtney Mowat, Shayla R Mosley, Afshin Namdar, et al.
BMC Psychiatry|January 1, 2015
Differentiating ADHD from oral language difficulties in children: role of movements and effects of stimulant medicationCarroll W Hughes, Joyce Pickering, Kristi Baker, et al.
Journal of Clinical Pathology|August 4, 2012
Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair statusViktor Hendrik Koelzer, Kristi Baker, Daniela Kassahn, et al.
Cancer|June 12, 2009
Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroupsInti Zlobec, Kristi Baker, Parham Minoo, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|January 21, 2015
Regulation of immune responses by the neonatal fc receptor and its therapeutic implicationsTimo Rath, Kristi Baker, Michal Pyzik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosisInti Zlobec, Kristi Baker, Luigi M Terracciano, et al.
International Journal of Molecular Sciences|August 18, 2017
A Critical Review on the Effect of Docosahexaenoic Acid (DHA) on Cancer Cell Cycle ProgressionMarnie Newell, Kristi Baker, Lynne M Postovit, et al.
Histopathology|November 1, 2011
Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancersInti Zlobec, Parham Minoo, Luigi Terracciano, et al.
Frontiers in Immunology|June 12, 2023
Short chain fatty acids prime colorectal cancer cells to activate antitumor immunityCourtney Mowat, Jasmine Dhatt, Ilsa Bhatti, et al.
Frontiers in Immunology|October 3, 2025
Correction: Short chain fatty acids prime colorectal cancer cells to activate antitumor immunityCourtney Mowat, Jasmine Dhatt, Ilsa Bhatti, et al.
The Journal of Experimental Medicine|July 23, 2021
Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN-driven CCL5 and CXCL10Courtney Mowat, Shayla R Mosley, Afshin Namdar, et al.
BMC Psychiatry|January 1, 2015
Differentiating ADHD from oral language difficulties in children: role of movements and effects of stimulant medicationCarroll W Hughes, Joyce Pickering, Kristi Baker, et al.
Journal of Clinical Pathology|August 4, 2012
Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair statusViktor Hendrik Koelzer, Kristi Baker, Daniela Kassahn, et al.
Cancer|June 12, 2009
Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroupsInti Zlobec, Kristi Baker, Parham Minoo, et al.
Pageof 7